Joseph Frankl1,2, Paolo Piaggi2, James E Foley2, Jonathan Krakoff2, Susanne B Votruba2. 1. Obesity and Diabetes Clinical Research Section, National Institute of Diabetes and Digestive and Kidney Diseases, National Institutes of Health, Phoenix, Arizona, USA. 2. University of Arizona College of Medicine, Tucson, Arizona, USA.
Abstract
OBJECTIVE: To assess the association of adipocyte size with cellular lipolysis and between cellular lipolysis and whole-body lipid oxidation. This study also assessed the association between adipocyte size and cellular lipolysis with weight and fat mass gain. METHODS: Subjects had assessment of percent body fat (%fat) and adipose tissue biopsy for in vitro lipolysis (n = 325), and a subset of subjects had measurement of whole-body lipid oxidation (n = 112). A subset of subjects (n = 243) returned for repeated measurements of body weight and composition (mean follow-up 8.2 ± 5.5 years). RESULTS: In vitro lipolysis (r = 0.47, P < 0.0001) and adipocyte size (r = 0.49, P < 0.0001) were strongly associated with %fat. In vitro lipolysis (P = 0.04) but not adipocyte size (P = 0.44) was associated with whole-body fat oxidation. Adipocyte size was not associated with rate of percent weight gain (P = 0.20) but was negatively associated with rate of percent fat mass gain (P = 0.01). In vitro lipolysis was negatively associated with rate of percent weight gain (P = 0.02) and had a marginal negative association with rate of percent fat mass gain (P = 0.08). CONCLUSIONS: These results indicate inherent characteristics of adipocytes, including size and lipolytic activity, may be important determinants of whole-body lipid oxidation and subsequent weight gain.
OBJECTIVE: To assess the association of adipocyte size with cellular lipolysis and between cellular lipolysis and whole-body lipid oxidation. This study also assessed the association between adipocyte size and cellular lipolysis with weight and fat mass gain. METHODS: Subjects had assessment of percent body fat (%fat) and adipose tissue biopsy for in vitro lipolysis (n = 325), and a subset of subjects had measurement of whole-body lipid oxidation (n = 112). A subset of subjects (n = 243) returned for repeated measurements of body weight and composition (mean follow-up 8.2 ± 5.5 years). RESULTS: In vitro lipolysis (r = 0.47, P < 0.0001) and adipocyte size (r = 0.49, P < 0.0001) were strongly associated with %fat. In vitro lipolysis (P = 0.04) but not adipocyte size (P = 0.44) was associated with whole-body fat oxidation. Adipocyte size was not associated with rate of percent weight gain (P = 0.20) but was negatively associated with rate of percent fat mass gain (P = 0.01). In vitro lipolysis was negatively associated with rate of percent weight gain (P = 0.02) and had a marginal negative association with rate of percent fat mass gain (P = 0.08). CONCLUSIONS: These results indicate inherent characteristics of adipocytes, including size and lipolytic activity, may be important determinants of whole-body lipid oxidation and subsequent weight gain.
Authors: W G Abbott; B V Howard; L Christin; D Freymond; S Lillioja; V L Boyce; T E Anderson; C Bogardus; E Ravussin Journal: Am J Physiol Date: 1988-09
Authors: Alessio Basolo; Mujtaba H Shah; Varsha Parthasarathy; Shannon Parrington; Mary Walter; Susanne B Votruba; Jonathan Krakoff; Paolo Piaggi; Douglas C Chang Journal: Obesity (Silver Spring) Date: 2020-04-30 Impact factor: 9.298
Authors: Torfinn S Madssen; Inger Thune; Vidar G Flote; Steinar Lundgren; Gro F Bertheussen; Hanne Frydenberg; Erik Wist; Ellen Schlichting; Hartmut Schäfer; Hans E Fjøsne; Riyas Vettukattil; Jon Lømo; Tone F Bathen; Guro F Giskeødegård Journal: Br J Cancer Date: 2018-11-07 Impact factor: 7.640
Authors: Mikael Rydén; Daniel P Andersson; Maria I Kotopouli; Erik Stenberg; Erik Näslund; Anders Thorell; Thorkild I A Sørensen; Peter Arner Journal: J Intern Med Date: 2022-06-07 Impact factor: 13.068
Authors: Brittany Begaye; Karyne L Vinales; Tim Hollstein; Takafumi Ando; Mary Walter; Clifton Bogardus; Jonathan Krakoff; Paolo Piaggi Journal: Diabetes Date: 2019-11-11 Impact factor: 9.461